Hibiscus sabdariffa on Fibroblast Growth Factor 21 (FGF21) on Diabetes Mellitus Type 2 Patients
DOI:
https://doi.org/10.55324/ijoms.v2i8.514Keywords:
fibroblast growth factor 21, hibiscus sabdariffa inn., diabetes mellitus type 2Abstract
FGF21 has a role in modulating the uptake of macronutrients in the body. It is produced by the liver in response to high carbohydrate intake and acts as a signal to the brain to reduce carbohydrate intake. Liver is the main site for FGF21 production under the regulation of Unfolding Protein Response (UPR) in hepatocytes. FGF21 has an important role in regulating peripheral glucose tolerance as well as lipid metabolism. FGF21 expression in the liver depends on the PKR-like ER kinase (PERK)–eukaryotic initiation factor 2? (eIF2?)–activating transcription factor 4 (ATF4) pathway. FGF21 can regulate the expression of glucose transporter 1, and increase glucose uptake. In addition, research shows that FGF21 can reduce blood sugar levels and also body weight in mice1. FGF21 can also increase insulin sensitivity by suppressing hepatic glucose production and increasing hepatic glycogen content, so that this can improve systemic glucose intolerance and insulin resistance. The researchers attempted to discover the influence of Hibiscus sadariffa on FGF21 on Diabetes mellitus type 2 patients. The method used was literature review with data generated from various sources such as Google Scholar, Scopus, and Pubmed. FGF21 has an effect on the function of ? and ß cells in the pancreas organ. In the islets of the pancreatic organs of rats with DM, administration of FGF21 increased insulin levels, induced insulin secretion, and inhibited glucagon secretion.
References
Alam, S., Hasan, Md. K., Neaz, S., Hussain, N., Hossain, Md. F., & Rahman, T. (2021). Diabetes mellitus: Insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology, 2(2), 36–50. https://doi.org/10.3390/diabetology2020004
Amit Sapra, & Priyanka Bhandari. (2021). Diabetes mellitus. StatPearls [Internet].
Bule, M., Albelbeisi, A. H., Nikfar, S., Amini, M., & Abdollahi, M. (2020). The antidiabetic and antilipidemic effects of Hibiscus sabdariffa: A systematic review and meta-analysis of randomized clinical trials. Food Research International, 130, 108980. https://doi.org/10.1016/j.foodres.2020.108980
Da-Costa-Rocha, I., Bonnlaender, B., Sievers, H., Pischel, I., & Heinrich, M. (2014). Hibiscus sabdariffa L. – A phytochemical and pharmacological review. Food Chemistry, 165, 424–443. https://doi.org/10.1016/j.foodchem.2014.05.002
Emanuelli, B., Vienberg, S. G., Smyth, G., Cheng, C., Stanford, K. I., Arumugam, M., Michael, M. D., Adams, A. C., Kharitonenkov, A., & Kahn, C. R. (2014). Interplay between FGF21 and insulin action in the liver regulates metabolism. Journal of Clinical Investigation, 124(2), 515–527. https://doi.org/10.1172/JCI67353
Fomison-Nurse, I., Saw, E. E. L., Gandhi, S., Munasinghe, P. E., van Hout, I., Williams, M. J. A., Galvin, I., Bunton, R., Davis, P., Cameron, V., & Katare, R. (2018). Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells. Cell Death & Differentiation, 25(7), 1336–1349. https://doi.org/10.1038/s41418-017-0047-6
Fu, T., & Kemper, J. K. (2016). MicroRNA-34a and impaired FGF19/21 signaling in obesity (pp. 175–196). https://doi.org/10.1016/bs.vh.2016.02.002
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 Diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275
Gao, R.-Y., Hsu, B.-G., Wu, D.-A., Hou, J.-S., & Chen, M.-C. (2019). Serum fibroblast growth factor 21 levels are positively associated with metabolic syndrome in patients with type 2 diabetes. International Journal of Endocrinology, 2019, 1–8. https://doi.org/10.1155/2019/5163245
Ge, X., Wang, Y., Lam, K. S., & Xu, A. (2012). Metabolic actions of FGF21: molecular mechanisms and therapeutic implications. Acta Pharmaceutica Sinica B, 2(4), 350–357. https://doi.org/10.1016/j.apsb.2012.06.011
InfoDATIN. (2020). Tetap produktif, cegah, dan atasi Diabetes mellitus.
Johansen, K. (1990). Hyperlipidemia in Diabetes mellitus: Pathogenesis, diagnosis, and pharmacological therapy. Annals of Saudi Medicine, 10(2), 194–201. https://doi.org/10.5144/0256-4947.1990.194
Kartinah, N. T., Komara, N., Noviati, N. D., Dewi, S., Yolanda, S., Radhina, A., Heriyanto, H., & Sianipar, I. R. (2022). Potential of Hibiscus sabdariffa Linn. in managing FGF21 resistance in diet?induced?obesity rats via miR?34a regulation. Veterinary Medicine and Science, 8(1), 309–317. https://doi.org/10.1002/vms3.653
Kong, M., Xie, K., Lv, M., Li, J., Yao, J., Yan, K., Wu, X., Xu, Y., & Ye, D. (2021). Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. Biomedicine & Pharmacotherapy, 133, 110975. https://doi.org/10.1016/j.biopha.2020.110975
Lewis, J. E., Ebling, F. J. P., Samms, R. J., & Tsintzas, K. (2019). Going back to the biology of FGF21: New insights. Trends in Endocrinology & Metabolism, 30(8), 491–504. https://doi.org/10.1016/j.tem.2019.05.007
Matikainen, N. (2014). Fibroblast growth factor 21 is a regulator of energy metabolism in the liver and adipose tissue. In Nutrition in the Prevention and Treatment of Abdominal Obesity (pp. 461–472). Elsevier. https://doi.org/10.1016/B978-0-12-407869-7.00039-8
Minard, A. Y., Tan, S.-X., Yang, P., Fazakerley, D. J., Domanova, W., Parker, B. L., Humphrey, S. J., Jothi, R., Stöckli, J., & James, D. E. (2016). mTORC1 is a major regulatory node in the fgf21 signaling network in Adipocytes. Cell Reports, 17(1), 29–36. https://doi.org/10.1016/j.celrep.2016.08.086
R.A. Mans, D., & Grant, A. (2017). “A thing of beauty is a joy forever”. Plants and plant-based preparations for facial care in Suriname. Clinical and Medical Investigations, 2(4). https://doi.org/10.15761/CMI.1000143
Riaz, G., & Chopra, R. (2018). A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L. Biomedicine & Pharmacotherapy, 102, 575–586. https://doi.org/10.1016/j.biopha.2018.03.023
Sapra, A., & Bhandari, P. (2022). Diabetes mellitus.
So, W. Y., Cheng, Q., Chen, L., Evans-Molina, C., Xu, A., Lam, K. S. L., & Leung, P. S. (2013). High glucose represses ?-Klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets. Diabetes, 62(11), 3751–3759. https://doi.org/10.2337/db13-0645
Tezze, C., Romanello, V., & Sandri, M. (2019). FGF21 as modulator of metabolism in health and disease. Frontiers in Physiology, 10. https://doi.org/10.3389/fphys.2019.00419
Wang, S.-C., Lee, S.-F., Wang, C.-J., Lee, C.-H., Lee, W.-C., & Lee, H.-J. (2011). Aqueous extract from Hibiscus sabdariffa Linnaeus ameliorate diabetic nephropathy via regulating oxidative status and Akt/Bad/14-3-3 ? in an experimental animal model. Evidence-Based Complementary and Alternative Medicine, 2011, 1–9. https://doi.org/10.1093/ecam/nep181
World Health Organization. (n.d.). Diabetes. Retrieved January 28, 2022, from https://www.who.int/news-room/fact-sheets/detail/diabetes
Zhang, J., Weng, W., Wang, K., Lu, X., Cai, L., & Sun, J. (2018). The role of FGF21 in type 1 diabetes and its complications. International Journal of Biological Sciences, 14(9), 1000–1011. https://doi.org/10.7150/ijbs.25026
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Sumayya Nuri Fuadana Aulia Ul Haque, Gulshan Fahmi El Bayani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
